Geopolitical Risks Rise as Gaza Flotilla Activists Allege Mistreatment by Israeli Forces Trainline Raises FullYear Outlook for Second Time in Fiscal 2026 Morning Squawk Micron Milestone Dicks Earnings Paxton Defeats Cornyn Lead Investor Agenda Corpus Christis Rise as Americas Premier Energy Export Hub Shale Boom Infrastructure and Global Demand Qualcomm Shares Surge as Investors Anticipate AI Device Boom Huawei to Introduce Enhanced Smartphone Chips This Fall Intensifying Competition with Nvidia and Apple Dow Q1 2026 Earnings EPS Surprises to the Upside Amid Challenging Conditions RDIB Q3 2025 Earnings Significant EPS Miss Raises Concerns TXRH Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Edges Lower ASND Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Edge Lower STKS Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment Hudson Technologies HDSN Edges Higher as Stock Tests Key Resistance Level Beauty Health Company SKIN Surges 2481 as Price Approaches Key Resistance German American Bancorp GABC Nudges Lower as Regional Bank Sector Faces Headwinds STRF Preferred Stock Holds Steady Near 101 Amid Tight Trading Range BT Brands Inc BTBD Edges Higher as Bullish Momentum Tests Key Resistance German Business Confidence Unexpectedly Improves Despite Iran War Energy Disruption UP Q1 2026 Earnings Steep Loss Reported as Stock Surges on Strategic Progress CDT Equity Inc Warrant CDTTW Holds at 001 A Penny Stock at a Trading Crossroads OWLT Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Despite Stock Decline LTH Q1 2026 Earnings EPS Surprise Drives Qualified Optimism Despite Weak Stock Reaction Virgin Galactic Q1 2026 Earnings Loss Narrows as Company Reports BetterThanExpected EPS SSC Technologies Q1 2026 Earnings Slight EPS Beat Amid Steady Operations CCL Q1 2026 Earnings Cruise Operator Beats EPS Expectations Despite Market Pullback PVH Q1 2026 Earnings EPS Surges Past Estimates Amidst Strong Brand Performance FBIO Q4 2025 Earnings Deep EPS Miss Highlights Challenges for PreRevenue Biotech